PRIMARY BRAIN-TUMORS DIFFER IN THEIR EXPRESSION OF OCTAMER DEOXYRIBONUCLEIC-ACID BINDING TRANSCRIPTION FACTORS FROM LONG-TERM CULTURED GLIOMA CELL-LINES
E. Schreiber et al., PRIMARY BRAIN-TUMORS DIFFER IN THEIR EXPRESSION OF OCTAMER DEOXYRIBONUCLEIC-ACID BINDING TRANSCRIPTION FACTORS FROM LONG-TERM CULTURED GLIOMA CELL-LINES, Neurosurgery, 34(1), 1994, pp. 129-135
NERVOUS SYSTEM-SPECIFIC TRANSCRIPTION factors that bind to the octamer
ic deoxyribonucleic acid sequence motif ATGCAAAT (or ATTTGCAT) are kno
wn as N-Oct proteins. Neurons and glia contain the ubiquitous Oct-1 pr
otein and four polypeptide complexes termed N-Oct-2, N-Oct-3, N-Oct-4,
and N-Oct-5. Previously, we showed that N-Oct proteins are differenti
ally expressed by human neuroblastoma and glioblastoma cell lines in v
itro. We have now extended this work to freshly isolated human primary
and metastatic brain tumors. Contrary to brain tumor cell lines, of t
he five astrocytomas and three glioblastomas analyzed, all but two tum
ors displayed the complete N-Oct protein profile, irrespective of hist
opathological tumor grade. Two astrocytomas were negative for N-Oct-4.
Ten of 13 ependymomas exhibited N-Oct-2, N-Oct-3, and N-Oct-4 but lac
ked the N-Oct-5 complex. In contrast, brain metastases of two patients
with extracerebral carcinomas contained only Oct-1, and cerebral meta
stases from two cases of B cell lymphoma showed Oct-1 and Oct-2 comple
xes, the characteristic Oct protein pattern of B lymphocytes. Thus, me
tastatic carcinoma and lymphoma expressed a non-nervous system phenoty
pe of Oct proteins.